Axiles Bionics, a Brussels-based deeptech and medtech spin-off, has closed the first €6M tranche of its €8M Series A financing round.
The funding, led by PE Group and supported by EIC Fund, Finance&Invest.brussels, private investors, entrepreneurs, and the company's management team, will aid in globalizing their biomimetic prosthetic foot Lunaris.
Lunaris offers mechanical adaptability and embedded systems, currently used in clinical settings worldwide.
Axiles Bionics is focused on developing bionic devices at the intersection of robotics, artificial intelligence, and biomechanics to enhance mobility through prosthetics.
Their first product, Lunaris, is FDA and CE certified, mimicking natural walking patterns for lower limb amputees, with plans for future bionic technologies.
PE Group CEO Stefan Yee praises Axiles Bionics for setting new standards in robotic prosthetics, poised to transform amputees' quality of life globally.
European Innovation Council (EIC) Fund supports Axiles Bionics, acknowledging their commercial success and clinical advancements.
Axiles Bionics aims to introduce advanced bionics as a standard, improving mobility and well-being, with a vision to reshape the global prosthetic technology standard.
Investors like PE Group, EIC Fund, and Finance&Invest.brussels are providing financial and strategic support to Axiles Bionics for their innovative advancements in prosthetics.